Charles Schwab Investment Management Inc Ocular Therapeutix, Inc Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,095,455 shares of OCUL stock, worth $13.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,095,455
Previous 1,112,793
1.56%
Holding current value
$13.7 Million
Previous $8.16 Million
24.63%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding OCUL
# of Institutions
202Shares Held
137MCall Options Held
743KPut Options Held
321K-
Deep Track Capital, LP Greenwich, CT14.3MShares$178 Million4.71% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$173 Million98.75% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$159 Million23.46% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$144 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.39MShares$105 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $961M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...